Vivaglobin and injection site erythema Patient Reports February 11, 2012

Vivaglobin Side Effects Report #5128427-3
Vivaglobin side effect was reported by a Physician from UNITED STATES on Sept 27, 2006. Female patient, 43 years of age, weighting 127.0 lb, was diagnosed with immunoglobulins and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: cough, injection site erythema, liver function test abnormal, migraine , nausea , nonspecific reaction. Vivaglobin dosage: 10 ML DAILY SC. Patient was hospitalized. Patient recovered.

Vivaglobin Side Effects Report #6125175-8
Vivaglobin side effect was reported by a Physician from UNITED STATES on Mar 11, 2009. Female patient, 64 years of age, weighting 175.0 lb, was diagnosed with immunodeficiency common variable and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: agitation, infusion related reaction, infusion site pruritus, injection site erythema, neurological symptom. Vivaglobin dosage: 46 ML Q1W SC. During the same period patient was treated with PREVACID. Patient was hospitalized and became disabled. Patient recovered.

Vivaglobin Side Effects Report #5128484-4
Vivaglobin side effect was reported by a Health Professional from UNITED STATES on Sept 20, 2006. Female patient, 43 years of age, weighting 160.6 lb, was diagnosed with immunodeficiency common variable and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: cough, injection site erythema, liver function test abnormal, migraine , nausea . Vivaglobin dosage: unknown. During the same period patient was treated with IMMUNE GLOBULINE SUBCUTANEOUS. Patient was hospitalized. Patient recovered.

Vivaglobin Side Effects Report #5145461-8
Vivaglobin side effect was reported by a Physician from UNITED STATES on Oct 16, 2006. Female patient, 43 years of age, weighting 127.0 lb, was diagnosed with immunodeficiency common variable and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: agitation, anxiety , convulsion, cough, injection site erythema, liver function test abnormal, migraine , nausea . Vivaglobin dosage: 10 ML DAILY SC; 20 ML DAILY SC. Patient was hospitalized. Patient recovered.


Vivaglobin Side Effects Report #5573990-1
Vivaglobin side effect was reported by a Physician from UNITED STATES on Dec 05, 2007. Female patient, 34 years of age, weighting 125.0 lb, was diagnosed with immunodeficiency common variable and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: injection site erythema, injection site pain, medical device complication, oedema peripheral. Vivaglobin dosage: unknown. During the same period patient was treated with ADVAIR DISKUS, ASTELIN, CLARINEX, COMBIVENT, DUONEB. Patient was hospitalized. Patient recovered.

Vivaglobin Side Effects Report #5921506-X
Vivaglobin side effect was reported by a Physician from UNITED KINGDOM on Sept 26, 2008. Female patient, child 11 years of age, was diagnosed with epstein-barr virus infection and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: injection site erythema, injection site infection, injection site mass, injection site pain, injection site reaction, product quality issue. Vivaglobin dosage: 30 ML Q1W SC. Patient recovered.

Vivaglobin Side Effects Report #5968168-3
Vivaglobin side effect was reported by a Physician from UNITED KINGDOM on Nov 12, 2008. Female patient, child 11 years of age, was diagnosed with epstein-barr virus infection and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: injection site erythema, injection site infection, injection site mass, injection site pain, injection site reaction. Vivaglobin dosage: 30 ML Q1W SC. Patient was hospitalized. Patient recovered.

Vivaglobin Side Effects Report #5594543-5
Vivaglobin side effect was reported by a Health Professional from UNITED KINGDOM on Jan 02, 2008. Female patient, 45 years of age, weighting 232.4 lb, was diagnosed with combined immunodeficiency and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: contusion, erysipelas, injection site erythema, injection site rash, injection site swelling, migraine , rash erythematous, skin reaction. Vivaglobin dosage: 114 MG DAILY SC; 114 ML Q1W SC. During the same period patient was treated with PHYLOCONTIN, QVAR, SEREVENT, ATROVENT, ALBUTEROL, QUININE SULPHATE, PREGABALIN. Patient recovered.

Vivaglobin Side Effects Report #5625210-7
Vivaglobin side effect was reported by a Physician from UNITED KINGDOM on Jan 17, 2008. Female patient, 45 years of age, weighting 232.4 lb, was diagnosed with combined immunodeficiency and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: erysipelas, infusion related reaction, infusion site bruising, infusion site rash, injection site erythema, injection site swelling, local reaction, migraine , rash erythematous. Vivaglobin dosage: 114 ML Q1W; SC. During the same period patient was treated with PHYLLOCONTIN, QVAR, SEREVENT, ATROVENT, ALBUTEROL. Patient recovered.


Vivaglobin Side Effects Report #5581314-9
Vivaglobin side effect was reported by a Health Professional from UNITED KINGDOM on Dec 14, 2007. Female patient, 46 years of age, was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: erysipelas, injection site erythema, injection site swelling. Vivaglobin dosage: 114 DAILY SC; 114 ML Q1W SC. Patient recovered.